Skip to main content
S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,787.00+5.07%ETH$2,431.65+7.47%GOLD$4,134.30+1.51%OIL$87.17-1.08%
Smart Investors Daily
SID Premium
VT

OTC · VTRLY

Vitrolife AB (publ)

Healthcare · Medical - Devices

$10.25

Up+$0.00 (+0.00%)

Updated Nov 5, 2026, 4:16 AM

SID Score

4.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2.1B
P/E ratio
42.84
Dividend yield
1.11%
52-week range
— – —
Volume
289
Avg. volume
53

Price performance · VTRLY

VTRLY price history

1M range · 0 trading sessions · Daily adjusted prices

VTRLY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest VTRLY news

The latest Smart Investors Daily articles mentioning VTRLY.

Stock researchCompany · Overview

VTRLY research

Overview

Company profile and research snapshot.

Company profile

VITROLIFE AB UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
VTRLY recent ratings
DateFirmRatingTarget
Jul 20, 2026PARETO SECURITIES ASHold—
Jul 17, 2026HANDELSBANKEN CAPITAL MARKETSHold—
Jul 17, 2026DNB CARNEGIEBuy—
Jul 8, 2026HANDELSBANKEN CAPITAL MARKETSHold—
Jul 7, 2026HANDELSBANKEN CAPITAL MARKETSHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 24, 2026

Is Vitrolife (OM:VITR) Cheap After Strong Q3 Earnings Or Is Recovery Priced In?

Vitrolife earnings event and why it matters now Vitrolife (OM:VITR) has just reported third quarter 2026 earnings, with sales of SEK 884 million and net income of SEK 127 million, compared with SEK 835 million and SEK 102 million a year earlier. Vitrolife’s latest earnings drop into a story of sharp short term momentum and longer term pain, with a 90 day share price return of 27.7% and a 1 year total shareholder return that has fallen 27.3%, signaling that sentiment has improved recently but...

Yahoo · Feb 17, 2026

European Stocks That May Be Trading Below Their Estimated Value In February 2026

As European markets experience volatility amid concerns about AI disruption and digest strong U.S. job data, the pan-European STOXX Europe 600 Index has reached new highs but remains largely unchanged. In this environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to capitalize on market inefficiencies.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By